| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Luye Pharma Group Ltd (HK: 2186)
2186 Technical Analysis
5
| As on 13th Jun 2025 2186 STOCK Price closed @ 3.92 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.93 & Strong Buy for SHORT-TERM with Stoploss of 3.10 we also expect STOCK to react on Following IMPORTANT LEVELS. |
2186STOCK Price
| Open | 3.88 | Change | Price | % |
| High | 4.03 | 1 Day | 0.10 | 2.62 |
| Low | 3.60 | 1 Week | 1.08 | 38.03 |
| Close | 3.92 | 1 Month | 1.90 | 94.06 |
| Volume | 288821800 | 1 Year | 0.18 | 4.81 |
| 52 Week High 3.75 | 52 Week Low 1.77 | ||||
HK Hong Kong Most Active Stocks
| 1033-OL | 0.80 | 25.00% |
| 1033 | 0.80 | 25.00% |
| 0467 | 0.54 | 22.73% |
| 0568 | 4.04 | 75.65% |
| CSHK100 | 2090.72 | -0.74% |
| 3988 | 4.57 | -1.72% |
| 1060 | 1.01 | -1.94% |
| 0020 | 1.41 | -4.08% |
| 0020-OL | 1.41 | -4.08% |
| 43 | 1.14 | 0.00% |
HK Hong Kong Top Gainers Stocks
HK Hong Kong Top Losers Stocks
| 2186 Daily Charts |
2186 Intraday Charts |
Whats New @ Bazaartrend |
2186 Free Analysis |
|
|
2186 Important Levels Intraday
| RESISTANCE | 4.75 |
| RESISTANCE | 4.48 |
| RESISTANCE | 4.32 |
| RESISTANCE | 4.15 |
| SUPPORT | 3.69 |
| SUPPORT | 3.52 |
| SUPPORT | 3.36 |
| SUPPORT | 3.09 |
2186 Forecast June 2025
| 4th UP Forecast | 6.68 |
| 3rd UP Forecast | 5.79 |
| 2nd UP Forecast | 5.25 |
| 1st UP Forecast | 4.7 |
| 1st DOWN Forecast | 3.14 |
| 2nd DOWN Forecast | 2.59 |
| 3rd DOWN Forecast | 2.05 |
| 4th DOWN Forecast | 1.16 |
2186 Weekly Forecast
| 4th UP Forecast | 4.59 |
| 3rd UP Forecast | 4.38 |
| 2nd UP Forecast | 4.24 |
| 1st UP Forecast | 4.11 |
| 1st DOWN Forecast | 3.73 |
| 2nd DOWN Forecast | 3.60 |
| 3rd DOWN Forecast | 3.46 |
| 4th DOWN Forecast | 3.25 |
2186 Forecast2025
| 4th UP Forecast | 8.47 |
| 3rd UP Forecast | 7.01 |
| 2nd UP Forecast | 6.11 |
| 1st UP Forecast | 5.21 |
| 1st DOWN Forecast | 2.63 |
| 2nd DOWN Forecast | 1.73 |
| 3rd DOWN Forecast | 0.83 |
| 4th DOWN Forecast | -0.63 |
Luye Pharma Group Ltd ( HK Hong Kong Symbol : 2186 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
2186 Business Profile
Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian cancer and treatment for metastatic carcinoma of ovary; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Tiandixin, a product used as an adjuvant therapy for malignant tumors, malignant hydrothorax and ascites, and respiratory infections; and Yitaida for acute promyelocytic leukemia and liver cancer. It also provides Rykindo, an injection for the treatment of acute and chronic schizophrenia; Seroquel and Seroquel XR for the treatment of schizophrenia and manic episodes of bipolar affective disorders; Rivastigmine Transdermal Patch for the treatment of Alzheimer's disease; Fentanyl Transdermal Patch for the treatment of cancer pain; and Buprenorphine Transdermal Patch for the treatment of chronic pain. In addition, it offers Beixi, an acarbose capsule for diabetes; Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation; Beitangning, a pioglitazone hydrochloride capsule to control blood glucose; Nuosen for acute upper digestive tract hemorrhage; and Sailimai for the treatment of diarrhea. Further, it provides Xuezhikang, a lipid adjusting capsule; Maitongna for cerebral edema and swelling by trauma; Oulai, a compound sodium aescinate gel for local swelling; Oukai for the treatment of soft tissue swelling and venous edema; Fengshiye for patients who have pains in bones, joints, and limbs; Apleek Transdermal Patch for contraception; Sidinuo for osteoporosis; and glucosamine hydrochloride tablets for osteoarthritis. Additionally, it distributes and sells pharmaceutical drugs; and manufactures and sells of biopharmaceutical products. The company was founded in 1994 and is headquartered in Yantai, the People's Republic of China. Address: No. 15 Chuang Ye Road, Yantai, China, 264003
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service